Cleared Traditional

K140110 - FLEXTIP PLUS EPIDURAL CATHETER

Also marketed or referenced as:
FLEXBLOCK CONTINOUS PERIPHERAL NERVE BLOCK CATHETER KIT/SET

K140110 is an FDA 510(k) clearance for FLEXTIP PLUS EPIDURAL CATHETER, manufactured by Teleflex, Inc.. The device is a Class 2 Anesthesiology device with product code BSO cleared through the Traditional 510(k) pathway after a 436-day FDA review.

K140110 · Teleflex, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2015
Decision
436d
Days
Class 2
Risk

K140110 is an FDA 510(k) clearance for the FLEXTIP PLUS EPIDURAL CATHETER. Classified as Catheter, Conduction, Anesthetic (product code BSO), Class II - Special Controls.

Submitted by Teleflex, Inc. (Reading, US). The FDA issued a Cleared decision on March 27, 2015 after a review of 436 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5120 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Teleflex, Inc. devices

FDA 510(k) Submission Details - K140110

510(k) Number K140110 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 15, 2014
Decision Date March 27, 2015
Days to Decision 436 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
296d slower than avg
Panel avg: 140d · This submission: 436d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BSO Device Classification - Class 2, Special Controls

Product Code BSO Catheter, Conduction, Anesthetic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BSO Catheter, Conduction, Anesthetic

All 46
Devices cleared under the same product code (BSO) and FDA review panel - the closest regulatory comparables to K140110.
Perifix and Contiplex Catheter
K153297 · B.Braun Medical, Inc. · Aug 2016
E-Cath
K152952 · PAJUNK GmbH Medizintechnologie · Jul 2016
Medline Epidural Catheter
K150731 · Medline Industries, Inc. · Mar 2016
PERIFIX ONE PEDIATRIC CATHETER, 20 GA. & 24 GA.
K090884 · B.Braun Medical, Inc. · Jun 2009
PAJUNK INFILTRALONG WOUND INFILTRATION CATHETER KIT
K080675 · PAJUNK GmbH Medizintechnologie · Jun 2008
BUSSE EPIDURAL CATHETER
K070465 · Busse Hospital Disposables, Inc. · Jul 2007